Ani Pharmaceuticals Inc. (ANIP)
Ani Pharmaceuticals Inc. (ANIP) Insider Trading
Directors, officers and holders of more than 10% of ANIP report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 213 transactions on file: 0 with code P, 34 with code S and 16 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | CAREY STEPHEN P. | SVP & CFO | S Sale | 2,850 | $72.87 | $207,680 |
| Oct 15, 2026 | Lalwani Nikhil | PRESIDENT & CEO | S Sale | 5,400 | $71.89 | $388,206 |
| Oct 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S Sale | 500 | $73.59 | $36,795 |
| Sep 29, 2026 | CAREY STEPHEN P. | SVP & CFO | S Sale | 2,850 | $73.00 | $208,050 |
| Sep 15, 2026 | Lalwani Nikhil | PRESIDENT & CEO | S Sale | 5,400 | $71.00 | $383,400 |
| Sep 14, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S Sale | 500 | $70.79 | $35,395 |
| Sep 11, 2026 | Thoma Jeanne | Director | S Sale | 1,000 | $71.53 | $71,530 |
| Aug 31, 2026 | CAREY STEPHEN P. | SVP & CFO | S Sale | 2,850 | $72.80 | $207,480 |
| Aug 25, 2026 | Lalwani Nikhil | PRESIDENT & CEO | S Sale | 5,400 | $74.30 | $401,220 |
| Aug 19, 2026 | Gosebruch Henry O | Director | A Award | 6,662 | Not measured | Not measured |
| Aug 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S Sale | 500 | $75.48 | $37,740 |
| Aug 10, 2026 | Gutwerg Ori | SVP, GENERICS | S Sale | 3,162 | $77.00 | $243,474 |
| Jul 29, 2026 | CAREY STEPHEN P. | SVP & CFO | S Sale | 2,850 | $81.36 | $231,876 |
| Jul 18, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | F Tax Payment | 2,466 | $79.20 | $195,307 |
| Jul 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S Sale | 500 | $81.84 | $40,920 |
| Jul 2, 2026 | CAREY STEPHEN P. | SVP & CFO | S Sale | 3,313 | $86.00 | $284,918 |
| Jul 2, 2026 | CAREY STEPHEN P. | SVP & CFO | M Exercise | 3,313 | $49.51 | $164,027 |
| Jul 2, 2026 | CAREY STEPHEN P. | SVP & CFO | M Exercise | 3,313 | $49.51 | $164,027 |
| Jun 29, 2026 | CAREY STEPHEN P. | SVP & CFO | S Sale | 2,850 | $84.12 | $239,742 |
| Jun 12, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S Sale | 500 | $82.03 | $41,015 |
| Jun 8, 2026 | HAUGHEY THOMAS | Director | S Sale | 2,000 | $80.88 | $161,760 |
| Jun 5, 2026 | CAREY STEPHEN P. | SVP & CFO | M Exercise | 3,312 | $49.51 | $163,977 |
| Jun 5, 2026 | CAREY STEPHEN P. | SVP & CFO | S Sale | 3,312 | $80.00 | $264,960 |
| Jun 5, 2026 | CAREY STEPHEN P. | SVP & CFO | M Exercise | 3,312 | $49.51 | $163,977 |
| May 21, 2026 | Thoma Jeanne | Director | A Award | 4,357 | Not measured | Not measured |
| May 21, 2026 | Pera Antonio R | Director | A Award | 4,357 | Not measured | Not measured |
| May 21, 2026 | Leonard Matthew J | Director | A Award | 4,357 | Not measured | Not measured |
| May 21, 2026 | TANNENBAUM RENEE P | Director | A Award | 4,357 | Not measured | Not measured |
| May 21, 2026 | HAUGHEY THOMAS | Director | A Award | 4,357 | Not measured | Not measured |
| May 13, 2026 | Walsh Patrick D | Director | S Sale | 10,000 | $80.63 | $806,300 |
| May 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S Sale | 500 | $78.16 | $39,080 |
| May 12, 2026 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S Sale | 459 | $79.21 | $36,357 |
| May 12, 2026 | Gutwerg Ori | SVP, GENERICS | S Sale | 2,772 | $79.50 | $220,374 |
| May 11, 2026 | Lalwani Nikhil | PRESIDENT & CEO | S Sale | 55,000 | $77.57 | $4,266,350 |
| May 11, 2026 | Walsh Patrick D | Director | S Sale | 3,973 | $80.75 | $320,820 |
| Apr 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S Sale | 500 | $77.95 | $38,975 |
| Mar 13, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | S Sale | 3,162 | $71.64 | $226,526 |
| Mar 13, 2026 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | S Sale | 500 | $72.62 | $36,310 |
| Mar 11, 2026 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S Sale | 4,772 | $74.91 | $357,471 |
| Mar 9, 2026 | Davis Krista | SVP, CHIEF HR OFFICER | S Sale | 5,087 | $74.13 | $377,099 |
| Mar 9, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | S Sale | 3,602 | $74.18 | $267,196 |
| Mar 7, 2026 | CAREY STEPHEN P. | SVP & CFO | F Tax Payment | 5,150 | $74.04 | $381,306 |
| Mar 7, 2026 | Lalwani Nikhil | PRESIDENT & CEO | F Tax Payment | 17,060 | $74.04 | $1,263,122 |
| Mar 7, 2026 | Gutwerg Ori | SVP, GENERICS | F Tax Payment | 3,314 | $74.04 | $245,369 |
| Mar 7, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | F Tax Payment | 3,314 | $74.04 | $245,369 |
| Mar 6, 2026 | Davis Krista | SVP, CHIEF HR OFFICER | S Sale | 1,485 | $75.00 | $111,375 |
| Mar 6, 2026 | Mutz Christopher | HEAD OF RARE DISEASE | S Sale | 2,121 | $74.22 | $157,421 |
| Mar 5, 2026 | CAREY STEPHEN P. | SVP & CFO | S Sale | 3,312 | $75.42 | $249,791 |
| Mar 5, 2026 | CAREY STEPHEN P. | SVP & CFO | M Exercise | 3,312 | $49.51 | $163,977 |
| Mar 5, 2026 | CAREY STEPHEN P. | SVP & CFO | S Sale | 4,000 | $75.56 | $302,240 |
The full Form 4 history is on the ANIP company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.